Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Asian Nat Prod Res ; 24(11): 1071-1077, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34951327

RESUMEN

The phytochemical investigation of the methanol extract of Ixeris sonchifolia led to the isolation and identification of nine analogs, including one new guaiane-type sesquiterpenoid, named ixerinoid A (1). The structure of 1 was determined by extensive analysis of the 1 D and 2 D nuclear magnetic resonance spectroscopic data, as well as quantum chemical calculations. Additionally, all the isolates were tested for their neuroprotective activity using the oxygen-glucose deprivation/reperfusion-induced SH-SY5Y cell injury model. Compounds 3, 5, 6, 8, and 9 displayed remarkable protective effects at concentrations of 1, 5, and 10 µM, respectively.


Asunto(s)
Asteraceae , Neuroblastoma , Fármacos Neuroprotectores , Daño por Reperfusión , Sesquiterpenos , Humanos , Estructura Molecular , Asteraceae/química , Sesquiterpenos/farmacología , Sesquiterpenos/química , Fármacos Neuroprotectores/farmacología
2.
Obes Surg ; 24(11): 1862-9, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24831461

RESUMEN

OBJECTIVE: This meta-analysis was conducted to determine the effect of percent excess weight loss (%EWL) after bariatric surgery on diabetes remission. METHODS: The Cochrane Library, PubMed, MEDLINE, Embase, and CINAHL were searched. All reports on %EWL involving humans and published in English between 1 January 1992 and 1 September 2013 were included in the analysis. RESULTS: Eight studies involving 1,247 patients who underwent bariatric surgery were selected. %EWL was positively associated with remission rate (WMD = 11.15, 95 % CI: 6.73-15.56, p < 0.01) in the Caucasian population. CONCLUSIONS: Patients with extensive weight loss were more likely to achieve T2DM remission after bariatric surgery. Further randomized controlled trials (RCTs) with uniform remission criterion should be performed to provide more reliable evidence.


Asunto(s)
Diabetes Mellitus Tipo 2/complicaciones , Obesidad Mórbida/cirugía , Pérdida de Peso , Cirugía Bariátrica/métodos , Diabetes Mellitus Tipo 2/sangre , Humanos , Obesidad Mórbida/complicaciones , Periodo Posoperatorio
3.
Am J Physiol Heart Circ Physiol ; 287(4): H1747-55, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15371268

RESUMEN

Mitochondrial F(1)F(0)-ATPase normally synthesizes ATP in the heart, but under ischemic conditions this enzyme paradoxically causes ATP hydrolysis. Nonselective inhibitors of this enzyme (aurovertin, oligomycin) inhibit ATP synthesis in normal tissue but also inhibit ATP hydrolysis in ischemic myocardium. We characterized the profile of aurovertin and oligomycin in ischemic and nonischemic rat myocardium and compared this with the profile of BMS-199264, which only inhibits F(1)F(0)-ATP hydrolase activity. In isolated rat hearts, aurovertin (1-10 microM) and oligomycin (10 microM), at concentrations inhibiting ATPase activity, reduced ATP concentration and contractile function in the nonischemic heart but significantly reduced the rate of ATP depletion during ischemia. They also inhibited recovery of reperfusion ATP and contractile function, consistent with nonselective F(1)F(0)-ATPase inhibitory activity, which suggests that upon reperfusion, the hydrolase activity switches back to ATP synthesis. BMS-199264 inhibits F(1)F(0) hydrolase activity in submitochondrial particles with no effect on ATP synthase activity. BMS-199264 (1-10 microM) conserved ATP in rat hearts during ischemia while having no effect on preischemic contractile function or ATP concentration. Reperfusion ATP levels were replenished faster and necrosis was reduced by BMS-199264. ATP hydrolase activity ex vivo was selectively inhibited by BMS-199264. Therefore, excessive ATP hydrolysis by F(1)F(0)-ATPase contributes to the decline in cardiac energy reserve during ischemia and selective inhibition of ATP hydrolase activity can protect ischemic myocardium.


Asunto(s)
Adenosina Trifosfato/metabolismo , Inhibidores Enzimáticos/farmacología , Imidazoles/farmacología , Isquemia Miocárdica/metabolismo , ATPasas de Translocación de Protón/metabolismo , Animales , Aurovertinas/química , Aurovertinas/farmacología , Supervivencia Celular/fisiología , Hidrólisis , Imidazoles/química , Masculino , Mitocondrias/enzimología , Miocardio/citología , Miocardio/metabolismo , Oligomicinas/química , Oligomicinas/farmacología , ATPasas de Translocación de Protón/antagonistas & inhibidores , Ratas , Ratas Sprague-Dawley , Desacopladores/química , Desacopladores/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA